Top Story

Younger age associated with genetic alterations in lung adenocarcinoma

March 22, 2017

Oncogenic genetic alterations occurred more frequently among patients aged younger than 40 years with lung adenocarcinoma than older patients, according to results of a retrospective study.

“Young patients with adenocarcinoma may be prime candidates for precision medicine strategies, because they tend to have more genetic alterations that can be treated with existing targeted therapies, leading to a compatible prognosis,” Kosuke Tanaka, MD, from the department of thoracic oncology at Aichi Cancer Center Hospital in Japan, and colleagues wrote.

AMA urges members of Congress to oppose American Health Care Act

March 22, 2017
The American Medical Association today released a letter to members of Congress urging them to oppose the American Health Care Act, citing projections that it will cost…
Meeting News Coverage

Dermatologist: Many Hispanics don't believe they're at risk for skin cancer

March 22, 2017
Although many Hispanic people believe they are not at risk for skin cancer, the population is more likely to be diagnosed with the disease in more advanced stages…
In the Journals

ASCO issues global guidance on HPV vaccination to prevent cervical cancer

March 22, 2017
The American Society of Clinical Oncology, or ASCO, has released the first guideline on primary prevention of cervical cancer that accommodate multiple regions of the…

ACP: New amendments to AHCA ‘even less acceptable’

March 22, 2017
ACP recently sent a letter to the Congressional leadership in strong opposition of the manager’s amendments to the American Health Care Act, arguing that several…
More News Headlines »

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Meeting News

VIDEO: Guidelines on using relative risks for skin cancer screenings

March 14, 2017
More »
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies


The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Current Issues
View the Current Issue
HemOnc Today